Galderma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Galderma SA (Galderma) is a pharmaceutical company. It develops and markets drugs, medical dermatology solutions and therapeutic skin care products for the treatment of hair, nail, and skin diseases. Galderma offers products for the treatment of skin conditions such as seborrheic dermatitis, androgenetic alopecia, glabellar lines, dry skin, acne, psoriasis, atopic dermatitis and steroid responsive dermatoses, onychomycosis, rosacea, and skin cancer. The company offers products leading brands such as Azzalure, Cetaphil, Clobex, Macrolane, and Oracea among several others. It markets products in India, Greece, Italy, Canada, Chile, Poland, the UK, and the US, among others. The company operates manufacturing facilities in France, Sweden, Canada, Brazil, Germany and Switzerland and research and development (R&D) centers in France, Sweden, the United States, Switzerland and Japan. Galderma is headquartered in Lausanne, Switzerland.

Galderma SA Key Recent Developments

Dec 20,2016: Appointment of Nestle Skin Health CEO ad interim
Jul 20,2016: Maruho and Galderma Strengthen Strategic Alliance in Japan
Jun 10,2016: Galderma Celebrates 20th Global Anniversary of Restylane
Feb 05,2016: Galderma, worldwide leader in Dermatology, has just announced that their R&D site in Sophia Antipolis-France has been granted the AFNOR ISO 22301 certification

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.